药品 & 医疗保健

关于

Global pharmaceutical and healthcare companies face a range of challenges: disputes over intellectual property (IP), 坚持不断变化的政府监管和并行的贸易挑战, 举几个例子. 巨大的机会也存在. 通过战略收购实现增长是可能的, 合资企业, 许可, 分布, 供应协议和国际贸易.

凭借彩票软件大全独特的全球能力, 包括在美国的丰富经验, 英国和欧盟制度, we understand the business and legal intricacies that pharmaceutical and healthcare companies face on a daily basis. We work with many of the leading global players in the pharmaceutical and healthcare sector on their dispute resolution, 公司和交易需求(主要融资), M&交易、诉讼等.).

彩票软件大全为跨国制药公司提供全方位的知识产权咨询, 反垄断, 商业诉讼与M&这一问题遍及美国、欧洲和亚洲.

彩票软件大全的律师曾打官司并赢得了一些史上最大的医药案件. 彩票软件大全成功地打官司高调的专利案件, 并就所有知识产权相关工作提供建议. 在美国, we are the most experienced of any law firm in so-called "reverse payment" cases brought by the Federal Trade Commission and/or private plaintiffs. We try high-stakes pharmaceutical cases in the US and represent pharmaceutical clients in some of the most-watched matters of the day. 在欧洲,彩票软件大全在平行贸易和该行业的其他问题上一直处于领先地位.We also offer clients strong capabilities in other areas such as the Foreign Corrupt 实践 Act, 《彩票软件》, 国际仲裁, 税, 环境与国际贸易.  We have deep connections with relevant national and international regulatory bodies in the pharmaceuticals and healthcare sector.

彩票软件大全为客户提供无与伦比的品牌保护经验, 专业, 仿制药公司应对反垄断的挑战. 彩票软件大全的经验包括政府和私彩票软件诉讼、审判和上诉. Our work on behalf of pharmaceutical clients includes defending claims such as "product-hopping,“沃克程序在美国专利商标局(USPTO)面前的欺诈, “虚假的”知识产权执法和食品和药物管理局(FDA)请愿, 以及其他拖延或抑制仿制药竞争的不当行为指控.

Our deep and longstanding connections with our clients ensure that our lawyers bring genuine commercial knowledge in the sector to each challenge. Our singular focus on understanding our clients' success and long-term strategies sets us apart. We commit to fully understanding our clients' businesses–their financial considerations and risk tolerance, 以及他们所处的竞争和监管环境.

 

查看所有律师在制药 & 医疗保健

 

奖 & 识别

唯一一支7次获得“年度最佳组别”的队伍
Law360

年度最佳生命科学小组
Law360 2018、2016、2014、2013

比利时-欧盟法规:制药,医疗器械 & 生物技术
2021年法律500强

在领先的排行榜上,交易金额一直排名前十.
汤森路透,Mergermarket和彭博社

Antitrust Firm of the Year; Dimitrios Drivas inducted into Life Sciences "Hall of Fame"
LMG生命科学2021年

Dimitrios Drivas (2013, 2014), 罗伯·米尔恩(2014, 2020), Jack Pace (2015) and Mark Gidley (2016) named to the "MVP" list of top lawyers in Life Sciences.
Law360

Several of our partners are noted for expertise in the pharmaceutical industry: "A prominent figure in the market whose considerable success has been founded on the impressive quality of…work.“因为在制药行业工作而出名。."
钱伯斯全球

经验

辉瑞和UCB, 2016年
We achieved a significant victory for Pfizer and UCB at trial in a Hatch-Waxman patent case against Mylan concerning the drug Toviaz, UCB开发并授权给辉瑞的是哪一种, 在美国有哪些市场. Toviaz在美国的年销售额约为2亿美元. The recent 4 day trial was against Mylan before Judge Gregory Sleet in the District of Delaware. Mylan claimed that it would present stronger invalidity arguments than those raised in the prior case, but the Court found Mylan's theories unconvincing in light of the persuasive and credible testimony from our chemistry experts. 在取证结束的时候, Judge Sleet issued a rare general verdict from the bench in favor of our clients on all five patents, 得出的结论是,迈兰连一个初步的证据都没有. The Court's decision confirms that no generic will receive final FDA approval to market a generic version of Toviaz until 2022.

歌公司., US$54.2015年,20亿收购信诺公司
彩票软件大全是Anthem公司的代理律师.该公司是美国最大的医疗福利公司之一.以20亿美元收购信诺公司的协议, a combination that will create a premiere health benefits company with critical diversification and scale to lead the transformation of health care delivery for consumers.

辉瑞公司.正在进行,
We represent Pfizer on a broad range of intellectual property matters: patent infringement cases, 基于专利和解的反垄断索赔案件, 以及指控辉瑞侵犯版权的案件. 彩票软件大全还开展与未来美国产品品牌相关的美国许可调查.

彩票软件大全为辉瑞公司取得了重大胜利. and its co-plaintiff Northwestern University in their patent infringement litigation against multiple generic drug companies involving patents covering Pfizer's blockbuster drug LYRICA® and certain of its therapeutic uses.

In an 反垄断 case (based on settlement of a patent case) involving the largest-selling pharmaceutical product in history, 立普妥(每年1250亿美元), 初审法庭完全同意了彩票软件大全以偏见驳回此案的动议.

联合银行,正在进行
彩票软件大全代理总部位于比利时的全球生物制药公司UCB在美国的专利侵权案件.  最近的一次重大胜利, 得到了美国联邦巡回上诉法院的支持, 在Apotex提出的专利侵权诉讼中为UCB辩护, 仿制药生产商, 在美国佛罗里达州南区地方法院. 经过三天的法庭审判,基本都是公平的索赔, 法院认为Apotex的专利是不可执行的, 以及其他对UCB有利的决定.

山德士,正在进行
彩票软件大全代表山德士, 大型制药企业, 在长期的平均批发价(AWP)诉讼中, which has included numerous federal and state court cases brought by state Attorneys General and a qui tam relator alleging false claims act, 欺诈和消费者保护索赔. 原告声称,制药公司报告了虚假和虚高的价格, 据称导致州医疗补助机构为处方药支付过多费用. 彩票软件大全取得了重大胜利,在两起诉讼完成时, 在每一个实例, the appellate court reversed substantial jury verdicts for the plaintiff state and issued a judgment in favor of Sandoz. These appellate victories combined to reverse more than US$100 million in judgments and set important precedents. 彩票软件大全对山德士的辩护正在进行中.

Hikma 药品 PLC, 2美元.2015年,650亿收购仿制药业务
彩票软件大全代理Hikma 药品 PLC的2美元.650亿美元收购美国仿制药业务, 罗克珊实验室和勃林格殷格翰罗克珊公司, 来自德国制药公司勃林格殷格翰.

齐默控股 US$13.2014年,以350亿美元收购Biomet
彩票软件大全代表齐默控股 Inc.该公司在肌肉骨骼健康解决方案方面处于世界领先地位.350亿美元收购Biomet公司.是世界领先的医疗器械制造商之一.

深圳海普瑞,蛋白质科学实验室收购,2014
彩票软件大全代表深圳海普瑞药业有限公司.有限公司., a Chinese company listed on the Shenzhen Stock Exchange, and its US subsidiary, Hepalink USA Inc.折合彩票软件民币337美元.500万收购科学蛋白质实验室, 有限责任公司, one of the leading global independent manufacturers and suppliers of active pharmaceutical ingredients. This transaction is one of a few acquisitions by a 彩票软件’s Republic of China public company of a US privately held target and constituted a major reorganization for our client pursuant to the relevant Chinese listing rules, 在美国和中国的多家顾问和机构的参与下.

Wellpoint公司., s1-800接触ale, 2014
彩票软件大全是WellPoint公司的代理律师., 全国最大的健康福利公司之一, 将旗下1-800 联系s子公司出售给私募股权公司Thomas H. Lee Partners及其相关资产出售1-800的眼镜.国际光学集团陆逊梯卡的com业务.

Par 药品和Paddock Holdings
We represented Par 药品和Paddock Holdings in a Federal Trade Commission (FTC) challenge to settlement agreements regarding AndroGel®. The Eleventh Circuit forcefully reaffirmed the principle that brand-generic patent settlement agreements are not actionable if they do not exceed the scope of the patent, 在驳回动议中向联邦贸易委员会支付了第一笔“延期付款”损失. 白色 & 情况下 was the only firm to have opposed the grant of certiorari among defense counsel; the others supported certiorari. 向最高法院上诉, the court rejected the position of the FTC automatically condemning "reverse payment" settlement agreements as per se illegal (the Third Circuit position). 法院认为,对此类协议的质疑应遵循理性原则, and we are currently handling cases for a variety of clients in the lower courts interpreting the Supreme Court's opinion.